A detailed history of Bourne Lent Asset Management Inc transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 38,822 shares of IDXX stock, worth $16.2 Million. This represents 7.44% of its overall portfolio holdings.

Number of Shares
38,822
Previous 38,642 0.47%
Holding current value
$16.2 Million
Previous $18.8 Million 4.14%
% of portfolio
7.44%
Previous 7.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$455.08 - $517.19 $81,914 - $93,094
180 Added 0.47%
38,822 $19.6 Million
Q2 2024

Aug 01, 2024

SELL
$468.04 - $548.53 $99,224 - $116,288
-212 Reduced 0.55%
38,642 $18.8 Million
Q1 2024

Apr 12, 2024

SELL
$515.08 - $576.87 $23,178 - $25,959
-45 Reduced 0.12%
38,854 $21 Million
Q4 2023

Jan 19, 2024

BUY
$391.37 - $557.56 $1.96 Million - $2.79 Million
5,003 Added 14.76%
38,899 $21.6 Million
Q3 2023

Oct 19, 2023

SELL
$432.42 - $556.67 $15.3 Million - $19.7 Million
-35,325 Reduced 51.03%
33,896 $14.8 Million
Q2 2023

Jul 17, 2023

SELL
$450.7 - $503.61 $401,123 - $448,212
-890 Reduced 1.27%
69,221 $34.8 Million
Q1 2023

Apr 24, 2023

SELL
$406.01 - $514.59 $91,352 - $115,782
-225 Reduced 0.32%
70,111 $35.1 Million
Q4 2022

Jan 23, 2023

SELL
$324.64 - $441.27 $990,152 - $1.35 Million
-3,050 Reduced 4.16%
70,336 $0
Q3 2022

Oct 31, 2022

SELL
$325.8 - $407.78 $260,640 - $326,224
-800 Reduced 1.08%
73,386 $23.9 Million
Q2 2022

Jul 27, 2022

SELL
$327.37 - $553.44 $311,001 - $525,768
-950 Reduced 1.26%
74,186 $26 Million
Q1 2022

Apr 26, 2022

SELL
$466.52 - $631.01 $1.82 Million - $2.46 Million
-3,900 Reduced 4.93%
75,136 $41.1 Million
Q4 2021

Jan 20, 2022

SELL
$586.54 - $666.48 $421,722 - $479,199
-719 Reduced 0.9%
79,036 $52 Million
Q3 2021

Oct 20, 2021

SELL
$621.9 - $705.76 $1.45 Million - $1.64 Million
-2,325 Reduced 2.83%
79,755 $49.6 Million
Q2 2021

Jul 28, 2021

SELL
$486.36 - $637.08 $887,607 - $1.16 Million
-1,825 Reduced 2.18%
82,080 $51.8 Million
Q1 2021

Apr 23, 2021

SELL
$465.18 - $551.79 $697,770 - $827,685
-1,500 Reduced 1.76%
83,905 $41.1 Million
Q4 2020

Jan 27, 2021

SELL
$383.85 - $499.87 $996,858 - $1.3 Million
-2,597 Reduced 2.95%
85,405 $42.7 Million
Q3 2020

Oct 19, 2020

SELL
$334.54 - $406.31 $66,908 - $81,262
-200 Reduced 0.23%
88,002 $34.6 Million
Q2 2020

Jul 20, 2020

SELL
$230.66 - $330.16 $442,867 - $633,907
-1,920 Reduced 2.13%
88,202 $29.1 Million
Q1 2020

Apr 17, 2020

SELL
$182.94 - $290.97 $73,176 - $116,388
-400 Reduced 0.44%
90,122 $21.8 Million
Q4 2019

Jan 24, 2020

SELL
$248.66 - $285.01 $164,115 - $188,106
-660 Reduced 0.72%
90,522 $23.6 Million
Q3 2019

Oct 24, 2019

SELL
$260.07 - $289.93 $1.81 Million - $2.02 Million
-6,955 Reduced 7.09%
91,182 $24.8 Million
Q2 2019

Jul 29, 2019

SELL
$215.53 - $275.33 $365,323 - $466,684
-1,695 Reduced 1.7%
98,137 $27 Million
Q1 2019

Apr 22, 2019

SELL
$178.02 - $225.69 $818,892 - $1.04 Million
-4,600 Reduced 4.4%
99,832 $22.3 Million
Q4 2018

Jan 28, 2019

BUY
$176.18 - $248.92 $16,737 - $23,647
95 Added 0.09%
104,432 $19.4 Million
Q3 2018

Oct 19, 2018

SELL
$218.82 - $254.46 $308,536 - $358,788
-1,410 Reduced 1.33%
104,337 $26 Million
Q2 2018

Jul 25, 2018

SELL
$185.56 - $227.9 $935,222 - $1.15 Million
-5,040 Reduced 4.55%
105,747 $23 Million
Q1 2018

Apr 20, 2018

SELL
$157.81 - $204.73 $37,558 - $48,725
-238 Reduced 0.21%
110,787 $21.2 Million
Q4 2017

Feb 06, 2018

SELL
$147.68 - $168.37 $88,608 - $101,022
-600 Reduced 0.54%
111,025 $17.4 Million
Q3 2017

Oct 16, 2017

BUY
$150.32 - $166.46 $16.8 Million - $18.6 Million
111,625
111,625 $17.4 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Bourne Lent Asset Management Inc Portfolio

Follow Bourne Lent Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourne Lent Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bourne Lent Asset Management Inc with notifications on news.